Co-morbid conditions associated with tuberculosis (TB): Results from a 1-day, point-prevalence study in 204,912 physician diagnosed patients from 880 cities and towns in India

K. Apte, M. Barne, S. Madas, J. Gogtay, S. Chhowwala, N. Maharajan, S. Salvi (Pune, Mumbai, India)

Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Session: Tuberculosis: epidemiology and public health management II
Session type: Thematic Poster Session
Number: 4456

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Apte, M. Barne, S. Madas, J. Gogtay, S. Chhowwala, N. Maharajan, S. Salvi (Pune, Mumbai, India). Co-morbid conditions associated with tuberculosis (TB): Results from a 1-day, point-prevalence study in 204,912 physician diagnosed patients from 880 cities and towns in India. Eur Respir J 2013; 42: Suppl. 57, 4456

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Number of tuberculosis (TB) cases reported by primary care physicians (PCPs) in India: Results of a 1-day point prevalence study in 880 urban cities and towns in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016


A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Association between COPD and other co-morbid conditions: Results from a 1-day, point-prevalence study in 2,04,912 patients from 860 cities and towns in India
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012


Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Comorbidities and MDR-TB treatment outcomes in Georgia- 2009-11 cohort
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Molecular epidemiological analysis of cases of pulmonary tuberculosis in patients with multiple admissions to TB hospital
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016


Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016

Treatment outcome among HIV positive and HIV negative TB patients in Chandigarh, India: A retrospective cohort study
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

The tale of two hospitals: Urban and suburban patients with tuberculosis and their outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Prevalence of pneumonia reported by primary care physicians (PCPs) in India: Results of a 1-day point prevalence study in 880 urban cities and towns in India
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Patient and health system delays for tuberculosis patients diagnosed in medical colleges of Puducherry in India
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Sputum culture conversion among the first cohorts of MDR-TB patients managed in Nigeria at a tertiary care hospital
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Case series of 83 XDR-TB patients in an urban hospital of Gujarat, India; an interim analysis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Tuberculosis (TB) out-patient clinic in a low prevalence country: a 5-year experience of a Northern Italian city
Source: Eur Respir J 2004; 24: Suppl. 48, 415s
Year: 2004

Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015